Vicarious Surgical (RBOT) Shares Outstanding (2020 - 2025)
Vicarious Surgical's (RBOT) quarterly Shares Outstanding (Entity) came in at $6.0 million in Q3 2025, up 0.93% year-on-year from $5.9 million in Q3 2024, and little changed on a QoQ basis from $5.9 million in Q2 2025.
Vicarious Surgical (RBOT) Shares Outstanding (2020 - 2025) Analysis & Trends
Vicarious Surgical (RBOT) has 6 years of Shares Outstanding (Entity) data on file, last reported at $6.0 million in Q3 2025.
- On a quarterly basis, Shares Outstanding (Entity) rose 0.93% year-over-year to $6.0 million in Q3 2025; TTM through Sep 2025 was $6.0 million, a 0.93% increase from a year earlier, with the FY2024 full-year figure at $5.9 million, up 20.94% from the prior year.
- Shares Outstanding (Entity) for Q3 2025 stood at $6.0 million, roughly flat from $5.9 million in the prior quarter.
- Over the last five years, Shares Outstanding (Entity) for RBOT reached as high as $6.0 million in Q3 2025 and fell as low as $1.3 million in Q3 2021.
- Historically, Shares Outstanding (Entity) has averaged $4.5 million across 5 years, with a median of $4.3 million in 2022.
- Across the five-year window, Shares Outstanding (Entity) dropped 24.4% in 2021 and jumped 209.4% in 2022, its largest moves.
- Year by year, Shares Outstanding (Entity) stood at $1.3 million in 2021, then jumped by 207.1% to $4.1 million in 2022, then gained by 19.88% to $4.9 million in 2023, then rose by 20.94% to $5.9 million in 2024, then rose by 1.17% to $6.0 million in 2025.
- Per Business Quant data, the three most recent Shares Outstanding (Entity) figures were $6.0 million in Q3 2025, $5.9 million in Q2 2025, and $5.9 million in Q1 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 1.74 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 382.90 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 1.28 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 1.48 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 579.20 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 385.10 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 951.57 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 456.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | 867.00 Mn |
| 10 | Vicarious Surgical | 654,984.55 | -9.14 Mn | - | 5.95 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 5.95 Mn |
| Sep 30, 2025 | 5.95 Mn |
| Jun 30, 2025 | 5.94 Mn |
| Mar 31, 2025 | 5.92 Mn |
| Dec 31, 2024 | 5.89 Mn |
| Sep 30, 2024 | 5.90 Mn |
| Jun 30, 2024 | 5.87 Mn |
| Mar 31, 2024 | 5.86 Mn |
| Dec 31, 2023 | 4.87 Mn |
| Sep 30, 2023 | 5.17 Mn |
| Jun 30, 2023 | 4.23 Mn |
| Mar 31, 2023 | 4.20 Mn |
| Dec 31, 2022 | 4.06 Mn |
| Sep 30, 2022 | 4.07 Mn |
| Jun 30, 2022 | 4.04 Mn |
| Mar 31, 2022 | 4.25 Mn |
| Dec 31, 2021 | 1.32 Mn |
| Sep 30, 2021 | 1.31 Mn |
| Jun 30, 2021 | 2.93 Mn |
| Mar 31, 2021 | 2.92 Mn |